Cargando…
A case report of biotin–thiamine-responsive basal ganglia disease in a Saudi child: Is extended genetic family study recommended?
BACKGROUND: Biotin–thiamine-responsive basal ganglia disease (BTRBGD) is a neurometabolic autosomal recessive (AR) disorder characterized by subacute encephalopathy with confusion, convulsions, dysarthria, and dystonia. The disease is completely reversible if treated early with biotin and thiamine,...
Autores principales: | Aljabri, Mohammad F., Kamal, Naglaa M., Arif, Moinuddin, AlQaedi, Asrar M., Santali, Enas Y.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059037/ https://www.ncbi.nlm.nih.gov/pubmed/27749535 http://dx.doi.org/10.1097/MD.0000000000004819 |
Ejemplares similares
-
Psychological Assessment of Patients With Biotin-Thiamine-Responsive Basal Ganglia Disease
por: Alfadhel, Majid, et al.
Publicado: (2017) -
Biotin-thiamine-responsive basal ganglia disease: A case report
por: Majumdar, Shamaita, et al.
Publicado: (2021) -
An unusually mild case of biotin-thiamine-responsive basal ganglia disease
por: Lail, Gurnoor, et al.
Publicado: (2023) -
Early treatment of biotin–thiamine–responsive basal ganglia disease improves the prognosis
por: Wesół-Kucharska, Dorota, et al.
Publicado: (2021) -
Biotin-Thiamine-Responsive Basal Ganglia Disease in Children: A Treatable Neurometabolic Disorder
por: Saini, Arushi G., et al.
Publicado: (2021)